Connect with Immucor at ISBT 2023

Immucor is excited to meet you during the 33rd Regional ISBT Congress in Gothenburg, Sweden, from June 18-20 on our booth #1925.

Our team of transfusion experts will be present throughout the conference to answer your questions, update you on all our recent product developments or to say simply hello after so long.

We are so excited to welcome you all!

Expand

Pre-Meeting Education Day

Collapse

Pre-Meeting Education Day

Date/Time: Sunday 18th June, 12.00-16.30 CEST

Location: Room G1, Level 2, Svenska Mässan, Gothenburg, Sweden

Register Now:

Collapse

Expand

Lunch Symposium

Collapse

Join Us for a Lunch Symposium

Date/Time: Tuesday 20th June, 12.00-13.30 CEST

Location: Room G3, Level 2, Svenska Mässan, Gothenburg, Sweden

More information to come on the agenda.

Seating is limited! Arrive early to secure your seat!

Collapse

Expand

In-Booth Demonstrations

Collapse

In-Booth Demonstrations

Collapse

Expand

Report with Confidence: ImmuLINK Panel-ID Demonstration

Collapse

Report with Confidence: ImmuLINK Panel-ID

Booth talk on ImmuLINK Panel ID Module

Join us to discover our newly launched antibody identification module!

Date/Time : June 19th and 20th – at 10.20 am

Location : Immucor booth #1925

Register Now:

Collapse

Don't forget, follow Immucor on social media...

...As we countdown to ISBT!

Connect

Upcoming Events,
Webinars & Workshops

View Events Calendar

Upcoming Event

Webinar: HLA Antibody Detection & Identification

When

May 31st 2023

Where

View

Upcoming Event

Transfusion Education Day - Atlanta, GA, USA

When

June 7th 2023

Where

Atlanta, GA

View

Upcoming Event

XXXIII Congreso de la Sociedad Española de Transfusión Sanguínea y Terapia Celular (SETS)

When

June 8th 2023

Where

View

Keep Up With Us

View All News & Blogs

News & Blogs

Werfen Completes Acquisition of Immucor, Inc.

WERFEN COMPLETES ACQUISITION OF IMMUCOR, INC., EXPANDING LEADERSHIP IN SPECIALIZED DIAGNOSTICS Werfen announced in November 2022 that it reached an agreement to acquire Immucor, Inc. for approximately US$2 billion. The transaction has received all necessary regulatory approvals. The Transfusion and...

Continue Reading View All